Sponsor or institution
Clinical trials and research at Mabswitch, INC.
As of November 12, 2026, Find a Trial lists 4 NIH-funded research projects at this institution, with $1.5 million in listed awards. Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 4NIH research projects
NIH-funded research (4)
Early-stage science funded by the US National Institutes of Health. Most of these projects don't enroll patients, but they show what is being worked on.
-
Affinity-tunable antibody-drug conjugate for high-grade serous ovarian cancer
A new antibody-drug therapy tailored to target a common ovarian cancer marker is being developed for patients whose cancer has stopped responding to platinum-based treatments.
-
Remote-controlled PC-CAR T cells for hard-to-treat solid tumors
A new drug-free approach aims to let immune cells recognize and fight certain solid cancers by remotely adjusting their activity against tumor targets.
-
Improving the production of lentiviral vectors for therapies
This study is working on better ways to make and clean up special tools called lentiviral vectors that help with gene therapy, so that they can be produced more easily and safely for people who need them.
-
Regulatable CAR-T cells for safer cancer treatment
This study is testing a new kind of CAR-T cell therapy that can be safely controlled in the body, aiming to provide a better and safer treatment option for people with different types of cancer, especially solid tumors.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.